POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame painful muscle condition and cut steroid dependence
Disease control CompletedThis study tested whether adding a drug called secukinumab to standard steroid treatment helps people with polymyalgia rheumatica (PMR) who recently had their symptoms return. About 381 adults aged 50+ received either secukinumab or a placebo injection alongside a tapering steroi…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope to ditch steroids for painful muscle condition
Disease control CompletedThis study tested if a drug called Rituximab could help people newly diagnosed with polymyalgia rheumatica (PMR) achieve remission without needing long-term steroid treatment. Steroids are the standard treatment but can have serious side effects. The trial compared Rituximab agai…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
First look: testing a new IV treatment for painful inflammatory diseases
Knowledge-focused CompletedThis study aimed to understand how the body processes a drug called secukinumab when given through an IV (intravenous) line, and to check its safety. It involved 65 adults with either giant cell arteritis (GCA) or polymyalgia rheumatica (PMR), two painful inflammatory conditions.…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC